ET Capital is focused on liberating the talent of the entrepreneurs we back.
ET Capital Limited
15a Water Lane
+44 (0)1223 236632
ADC Therapeutics SA, the innovative anti-cancer therapeutics business, has floated on the New York Stock Exchange. Demand for the issue was high with an upsized placing and shares trading at an immediate premium.
ADC Therapuetics announces positive results from pivotal Phase 2 clinical trial of its lead therapeutic.